GL1X · GenesisL1 explorer

MolNFT v1 · #144687 · protein

FGFR1 kinase complex with inhibitor SN36985

6C19 · Fibroblast growth factor receptor 1: “FGFR1 kinase complex with inhibitor SN36985”. X-ray diffraction, 2 ligands (YY7, SO4), 3 pockets (best druggability 0.68). MolNFT v1 #144687 on GenesisL1: 3D structure, binding sites and pockets…

PDB
6C19
Type
protein
Length
540 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Fibroblast growth factor receptor 1
EC
2.7.10.1
UniProt
P11362
Ligands
YY7, SO4
Pockets
3 · best druggability 0.68

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AFibroblast growth factor receptor 1 (EC 2.7.10.1)protein27640% helix, 15% strandP11362
BFibroblast growth factor receptor 1 (EC 2.7.10.1)protein26442% helix, 16% strandP11362

Ligands and binding sites

  • YY7 · 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-{(3S)-1-[(2E)-4-(dimethylamino)but-2-enoyl]pyrrolidin-3-yl}-7-(methylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15700.680.7869empty
22690.620.8029YY7
32220.600.8030YY7

Interfaces

1 interface between chains.

  • A–B · 399 Ų buried · 9 hydrogen bonds · protein-protein

Compared structures

  • 6C19 · FGFR1 kinase complex with inhibitor SN36985 · the same entry in another collection · chain A against A, TM-score 1.00
  • P11362 · AlphaFold monomer V2.0 prediction for fibroblast growth factor receptor 1 (P11362) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.